🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
GeneOne Life Science, Inc. (KRX:011000)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,670.00
-215.00 (-7.45%)
Sep 6, 2026, 3:08 AM KST

GeneOne Life Science Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
415.871,3191,1809,11113,26122,310
Short-Term Investments
5,175184.7566.19406.632,34285,094
Trading Asset Securities
231.18231.18-470.79--
Cash & Short-Term Investments
5,8221,7351,7469,98845,603107,404
Cash Growth
115.08%-0.67%-82.52%-78.10%-57.54%18.65%
Accounts Receivable
1,6071,7427,1826,6248,9807,438
Other Receivables
361.7349.041,050948.441,5981,975
Receivables
2,4872,6638,3107,65210,65910,091
Inventory
10,11113,42216,51114,89714,86410,688
Prepaid Expenses
1,008629.021,5421,2251,145706.46
Other Current Assets
431.2988.11525.52811793.085,744
Total Current Assets
19,85919,43728,63534,57373,063134,633
Property, Plant & Equipment
78,21395,400117,730111,399144,369110,382
Long-Term Investments
9.2515.3118.550.39147.49437.33
Other Intangible Assets
191.85208.41189.96385.99563.91643.1
Long-Term Deferred Tax Assets
97.91103.4221.7113.2836.4214.24
Other Long-Term Assets
4,1684,0434,7394,5864,6874,735
Total Assets
102,539119,207151,334151,008222,867250,857

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
24,76124,64120,17610,0667,49317,531
Accrued Expenses
4,1403,8204,9101,9712,3271,173
Short-Term Debt
9,5559,2013,3772,40512,2469,754
Current Portion of Leases
332.381,4722,8952,3961,9111,543
Other Current Liabilities
19,90014,67111,1476,0299,8584,758
Total Current Liabilities
58,68953,80642,50622,86733,83634,759
Long-Term Debt
18,95120,01816,3736,273--
Long-Term Leases
2,4942,2664,4806,0855,5097,103
Pension & Post-Retirement Benefits
154.17122.1224.12,096-820.35
Long-Term Deferred Tax Liabilities
27.7429.3154.83323.98457.33144.32
Other Long-Term Liabilities
2,3272,0682,1921,8721,5941,524
Total Liabilities
82,64278,30965,72939,51841,39544,350

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
18,17785,41080,03978,47477,75277,479
Additional Paid-In Capital
225,771223,175217,579215,555214,299209,871
Retained Earnings
-280,869-316,836-264,848-216,231-137,155-98,241
Treasury Stock
-2,955-2,955-2,955-2,955-2,955-2,955
Comprehensive Income & Other
59,77352,10455,79136,64729,53120,353
Shareholders' Equity
19,89740,89885,605111,489181,471206,507
Total Liabilities & Equity
102,539119,207151,334151,008222,867250,857

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
31,33232,95827,12617,16019,66618,400
Net Cash (Debt)
-25,510-31,223-25,379-7,17125,93789,004
Net Cash Growth
-----70.86%22.34%
Net Cash Per Share
-1410.62-1893.01-1597.03-461.181673.655994.19
Filing Date Shares Outstanding
18.0817.0415.9715.6515.5115.45
Total Common Shares Outstanding
18.0817.0415.9715.6515.5115.45
Working Capital
-38,830-34,369-13,87011,70539,22799,875
Book Value Per Share
1100.232400.115361.757122.6011701.4613362.75
Tangible Book Value
19,70540,69085,415111,103180,907205,864
Tangible Book Value Per Share
1089.632387.885349.857097.9511665.1013321.13
Land
3,3613,6073,7203,1394,0813,817
Buildings
69,41074,50576,19263,3741,4031,331
Machinery
53,34756,90455,31848,59915,19911,775
Construction In Progress
----104,66178,283
Leasehold Improvements
16,10017,23016,41414,86713,13912,124